Table 3.
BRCA1 exons involved | Confirmation by long-range PCR | Mutation designation [GenBank: L78833] | Suspected minimal effect on mRNAa | Fenotypeb | Number of families identified | Sequence at breakpoint 5'/3' |
1–2 | yes | Preisler-Adams et al. del 36.9 kbc [40] | not expressed [19] | HBOC | 1 | ψ gene/gene HR [40] |
5–14 | yes | g.21716_53298 del31583 | loss of 3/4 of coding sequence | HBC HBOC | 4 | LINE1/- |
Part of 11–12 | yes | g.34845_41405 del6561 | loss of 1/2 of coding sequence | HOC | 1 | -/LINE1 |
18–19 | yes | g.63651_65590 del1940 | p.Asp1692Ala fsX2 | HBOC | 1 | AluY/AluSp |
20 | yes | g.68764_75792 del7029 | p.His1732_Lys1759del | HBC | 1 | AluSq/AluSx |
21–22 | yes | g.77128_80906 del3779ins236 | p.Ile1760_Thr1802del | HBC | 2 | AluSx/AluJb |
aInferred from change at the DNA level.
bHBC – human breast cancer, HBOC – human breast and ovarian cancer, HOC – human ovarian cancer.
cBased on the BAC clone sequence AC060780.